NVCR - Novocure's (NVCR) CEO Asaf Danziger on Q2 2019 Results - Earnings Call Transcript
Novocure Limited (NVCR)
Q2 2019 Earnings Conference Call
July 25, 2019 8:00 AM ET
Company Participants
Ashley Cordova – Senior Vice President-Finance and Investor Relations
Bill Doyle – Executive Chairman
Asaf Danziger – Chief Executive Officer
Ely Benaim – Chief Medical Officer
Wilco Groenhuysen – Chief Financial Officer
Conference Call Participants
Vijay Kumar – Evercore
Esther Rajavelu – Oppenheimer
Cory Kasimov – JPMorgan
Greg Gilbert – SunTrust
Difei Yang – Mizuho Securities
David Nierengarten – Wedbush Securities
Presentation
Operator
Good day, ladies and gentlemen, and welcome to Novocure Second Quarter 2019 Performance Conference Call. [Operator